Cargando…
Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
CUEDC2, a newly reported protein, plays critical roles in many biological processes, such as cell cycle, inflammation and tumorigenesis, however, its expression in ovarian serious carcinoma is still poorly understood. In this study, we performed an immunohistochemical study on 101 cases of ovarian s...
Autores principales: | Wang, Aichun, Guo, Chao, Sun, Yunfei, Lu, Lijuan, Wang, Yun, Wang, Qiong, Zhang, Yan, Zhang, Hui, Wang, Li, Gu, Yiqun, Liu, Aijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439940/ https://www.ncbi.nlm.nih.gov/pubmed/26000046 http://dx.doi.org/10.7150/jca.11420 |
Ejemplares similares
-
CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling
por: Wang, Aichun, et al.
Publicado: (2019) -
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015) -
Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018) -
Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis
por: Liu, Hui, et al.
Publicado: (2020) -
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray
por: Wang, Shasha, et al.
Publicado: (2019)